Sensius has developed a cancer therapy device that uses proprietary thermal technology and software to treat head and neck cancer. Clinicians design unique thermal collars to provide thermotherapy alongside traditional cancer treatments. A study of 70 patients showed 81.8% had a complete response at 12 weeks following radiotherapy. The company is now working towards building a CE marked device, with 8 interested parties already intending to purchase. Sensius aims to establish thermotherapy as a key treatment modality for cancer patients and deliver optimized radiotherapy outcomes while balancing efficacy with quality of life.